Deubiquitinases and the new therapeutic opportunities offered to cancer
- PMID: 25605410
- PMCID: PMC4304536
- DOI: 10.1530/ERC-14-0516
Deubiquitinases and the new therapeutic opportunities offered to cancer
Abstract
Deubiquitinases (DUBs) play important roles and therefore are potential drug _targets in various diseases including cancer and neurodegeneration. In this review, we recapitulate structure-function studies of the most studied DUBs including USP7, USP22, CYLD, UCHL1, BAP1, A20, as well as ataxin 3 and connect them to regulatory mechanisms and their growing protein interaction networks. We then describe DUBs that have been associated with endocrine carcinogenesis with a focus on prostate, ovarian, and thyroid cancer, pheochromocytoma, and adrenocortical carcinoma. The goal is enhancing our understanding of the connection between dysregulated DUBs and cancer to permit the design of therapeutics and to establish biomarkers that could be used in diagnosis and prognosis.
Keywords: A20; BAP1; CYLD; UCHL1; USP22; USP7; ataxin 3; deubiquitinases.
© 2015 The authors.
Figures
Similar articles
-
Deubiquitinases in cancer.Onco_target. 2015 May 30;6(15):12872-89. doi: 10.18632/onco_target.3671. Onco_target. 2015. PMID: 25972356 Free PMC article. Review.
-
Toward understanding ubiquitin-modifying enzymes: from pharmacological _targeting to proteomics.Trends Pharmacol Sci. 2014 Apr;35(4):187-207. doi: 10.1016/j.tips.2014.01.005. Epub 2014 Apr 6. Trends Pharmacol Sci. 2014. PMID: 24717260 Review.
-
Could dysregulation of UPS be a common underlying mechanism for cancer and neurodegeneration? Lessons from UCHL1.Cell Biochem Biophys. 2013 Sep;67(1):45-53. doi: 10.1007/s12013-013-9631-7. Cell Biochem Biophys. 2013. PMID: 23695785 Review.
-
Ubiquitin becomes ubiquitous in cancer: emerging roles of ubiquitin ligases and deubiquitinases in tumorigenesis and as therapeutic _targets.Cancer Biol Ther. 2010 Oct 15;10(8):737-47. doi: 10.4161/cbt.10.8.13417. Epub 2010 Oct 15. Cancer Biol Ther. 2010. PMID: 20930542 Free PMC article. Review.
-
Deubiquitinases (DUBs) and DUB inhibitors: a patent review.Expert Opin Ther Pat. 2015;25(10):1191-1208. doi: 10.1517/13543776.2015.1056737. Epub 2015 Jun 16. Expert Opin Ther Pat. 2015. PMID: 26077642 Free PMC article. Review.
Cited by
-
Deubiquitinase Activity Profiling Identifies UCHL1 as a Candidate Oncoprotein That Promotes TGFβ-Induced Breast Cancer Metastasis.Clin Cancer Res. 2020 Mar 15;26(6):1460-1473. doi: 10.1158/1078-0432.CCR-19-1373. Epub 2019 Dec 19. Clin Cancer Res. 2020. PMID: 31857432 Free PMC article.
-
The gold complex auranofin: new perspectives for cancer therapy.Discov Oncol. 2021 Oct 20;12(1):42. doi: 10.1007/s12672-021-00439-0. Discov Oncol. 2021. PMID: 35201489 Free PMC article. Review.
-
Heat shock proteins: Biological functions, pathological roles, and therapeutic opportunities.MedComm (2020). 2022 Aug 2;3(3):e161. doi: 10.1002/mco2.161. eCollection 2022 Sep. MedComm (2020). 2022. PMID: 35928554 Free PMC article. Review.
-
_targetable Pathways for Alleviating Mitochondrial Dysfunction in Neurodegeneration of Metabolic and Non-Metabolic Diseases.Int J Mol Sci. 2021 Oct 23;22(21):11444. doi: 10.3390/ijms222111444. Int J Mol Sci. 2021. PMID: 34768878 Free PMC article. Review.
-
Hypoxia induces epithelial-mesenchymal transition in colorectal cancer cells through ubiquitin-specific protease 47-mediated stabilization of Snail: A potential role of Sox9.Sci Rep. 2017 Nov 21;7(1):15918. doi: 10.1038/s41598-017-15139-5. Sci Rep. 2017. PMID: 29162839 Free PMC article.
References
-
- Avvakumov GV, Walker JR, Xue S, Finerty PJ, Jr, Mackenzie F, Newman EM, Dhe-Paganon S. Amino-terminal dimerization, NRDP1–rhodanese interaction, and inhibited catalytic domain conformation of the ubiquitin-specific protease 8 (USP8) Journal of Biological Chemistry. 2006;281:38061–38070. doi: 10.1074/jbc.M606704200. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous